Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WI › JANESVILLE › SSM HEALTH CARE OF WISCONSIN, INC.

SSM HEALTH CARE OF WISCONSIN, INC.

NPI: 1194004408 · JANESVILLE, WI 53546 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 08/04/2011

$8.37M
Total Medicaid Paid
427,044
Total Claims
359,441
Beneficiaries
171
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMINERATH, JOSEPH (SYSTEM DIRECTOR GOV'T REIMBURSEMENT)
NPI Enumeration Date08/04/2011

Related Entities

Other providers sharing the same authorized official: MINERATH, JOSEPH

ProviderCityStateTotal Paid
SSM HEALTH CARE OF WISCONSIN, INC. MADISON WI $14.70M
SSM HEALTH CARE OF WISCONSIN INC BARABOO WI $9.78M
SSM HEALTH CARE OF WISCONSIN, INC MADISON WI $6.40M
RIPON MEDICAL CENTER INC RIPON WI $4.30M
AGNESIAN HEALTHCARE INC FOND DU LAC WI $2.25M
SSM HEALTH CARE OF WISCONSIN INC JANESVILLE WI $1.03M
AGNESIAN HEALTHCARE INC FOND DU LAC WI $172K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 34,767 $786K
2019 56,423 $1.10M
2020 54,016 $975K
2021 69,979 $1.27M
2022 72,164 $1.41M
2023 78,169 $1.52M
2024 61,526 $1.32M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 19,027 16,921 $1.20M
99284 Emergency department visit for the evaluation and management, high severity 18,275 15,551 $960K
96361 Intravenous infusion, hydration; each additional hour 6,439 5,328 $732K
80053 Comprehensive metabolic panel 21,418 17,730 $584K
99282 Emergency department visit for the evaluation and management, low to moderate severity 4,661 4,287 $335K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,838 3,492 $315K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,771 2,474 $202K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,759 1,632 $197K
80048 Basic metabolic panel (calcium, ionized) 7,569 6,316 $183K
70450 Computed tomography, head or brain; without contrast material 2,878 2,579 $174K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,888 3,404 $173K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 23,406 19,050 $168K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,212 1,995 $133K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 3,434 3,070 $132K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3,544 3,201 $115K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3,544 3,200 $110K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,453 1,368 $107K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,709 1,463 $93K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,546 2,292 $87K
59025 Fetal non-stress test 1,369 1,004 $86K
87086 Culture, bacterial; quantitative colony count, urine 6,234 5,505 $85K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3,279 3,003 $82K
84443 Thyroid stimulating hormone (TSH) 4,884 4,449 $81K
81001 14,332 12,399 $79K
81025 7,370 6,513 $79K
80061 Lipid panel 5,518 5,040 $78K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,695 2,504 $78K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,077 1,707 $68K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,395 1,148 $68K
83036 Hemoglobin; glycosylated (A1C) 5,178 4,785 $66K
80050 General health panel 3,466 3,236 $65K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2,889 2,606 $60K
85027 8,277 7,013 $59K
84702 1,920 1,334 $56K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 659 617 $54K
83655 1,682 1,573 $52K
84484 6,468 4,381 $51K
80306 2,825 2,536 $49K
86803 2,366 2,174 $47K
80143 1,208 1,076 $39K
82947 1,493 1,306 $38K
87081 1,760 1,634 $37K
87631 226 219 $35K
85610 3,455 2,583 $35K
83690 6,295 5,353 $34K
83605 4,448 3,370 $34K
83880 1,655 1,441 $33K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,118 2,849 $33K
84439 1,612 1,468 $31K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 330 315 $30K
86592 1,695 1,516 $29K
81003 5,432 4,810 $28K
74176 Computed tomography, abdomen and pelvis; without contrast material 427 376 $28K
87077 2,444 2,062 $26K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,278 969 $26K
86850 2,796 2,437 $26K
82962 3,975 2,115 $25K
G0378 Hospital observation service, per hour 1,424 1,107 $24K
71275 Computed tomographic angiography, chest, with contrast material 341 308 $24K
82607 1,585 1,470 $24K
87186 1,965 1,684 $22K
86762 1,361 1,195 $20K
82077 1,871 1,577 $19K
82728 1,112 988 $19K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 99 89 $18K
87210 2,540 2,299 $17K
83735 3,160 2,543 $16K
87340 1,851 1,640 $16K
84466 1,429 1,298 $15K
84145 964 807 $14K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 263 245 $14K
82105 327 304 $14K
83540 1,528 1,390 $14K
80179 1,147 1,039 $12K
82805 378 304 $12K
85379 1,524 1,359 $12K
72125 Computed tomography, cervical spine; without contrast material 552 486 $11K
86140 1,766 1,542 $11K
87040 1,433 711 $9K
80076 659 604 $8K
82746 585 547 $7K
86900 2,586 2,240 $7K
86901 2,632 2,276 $6K
88142 335 284 $6K
83021 116 102 $5K
85652 1,778 1,615 $4K
82043 801 718 $4K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 16 13 $4K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 116 105 $4K
82565 591 439 $4K
36415 Collection of venous blood by venipuncture 15,217 11,451 $4K
82570 846 729 $4K
86780 346 314 $3K
71045 Radiologic examination, chest; single view 5,253 4,620 $3K
82550 146 112 $3K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 8,438 7,109 $3K
71046 Radiologic examination, chest; 2 views 3,226 2,937 $2K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 14 13 $2K
85018 989 914 $2K
81329 14 13 $2K
85014 409 340 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 9,661 8,110 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 49 44 $1K
96375 Therapeutic injection; each additional sequential IV push 5,764 4,688 $1K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 126 116 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,717 1,871 $1K
86706 104 92 $1K
86038 88 78 $918.82
87634 18 15 $763.32
84550 138 105 $732.07
83970 17 13 $690.71
82784 28 25 $675.62
86787 58 54 $649.11
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,196 2,478 $604.87
95800 12 12 $579.12
36591 65 37 $523.92
85730 138 120 $486.93
84156 41 38 $477.23
87070 60 49 $400.64
86364 27 27 $371.48
83516 39 25 $369.68
84703 14 13 $333.63
86705 39 36 $328.46
83525 43 40 $309.35
87807 19 18 $230.32
87205 73 56 $199.38
97162 17 12 $190.44
87147 29 28 $155.33
88342 68 55 $118.59
96376 1,641 1,145 $109.51
J7030 Infusion, normal saline solution , 1000 cc 9,293 7,560 $34.06
73610 237 214 $18.61
73562 220 184 $18.17
88304 43 37 $17.54
73130 27 24 $17.27
J1885 Injection, ketorolac tromethamine, per 15 mg 6,251 5,200 $14.42
J2405 Injection, ondansetron hydrochloride, per 1 mg 7,530 6,141 $5.30
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,445 3,672 $4.95
J2765 Injection, metoclopramide hcl, up to 10 mg 944 818 $1.46
J1200 Injection, diphenhydramine hcl, up to 50 mg 2,103 1,662 $1.43
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 756 680 $1.35
J0696 Injection, ceftriaxone sodium, per 250 mg 922 739 $1.30
J3010 Injection, fentanyl citrate, 0.1 mg 4,984 4,261 $1.10
J1170 Injection, hydromorphone, up to 4 mg 3,390 2,333 $1.05
J2704 Injection, propofol, 10 mg 3,973 3,136 $0.89
J2250 Injection, midazolam hydrochloride, per 1 mg 4,234 3,666 $0.88
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 991 682 $0.84
A9270 Non-covered item or service 2,706 1,932 $0.64
J7120 Ringers lactate infusion, up to 1000 cc 4,869 3,760 $0.38
J7050 Infusion, normal saline solution, 250 cc 2,055 1,473 $0.07
J0690 Injection, cefazolin sodium, 500 mg 1,381 1,071 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,367 3,002 $0.00
J1790 Injection, droperidol, up to 5 mg 169 146 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 159 106 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 79 67 $0.00
J2060 Injection, lorazepam, 2 mg 233 177 $0.00
76801 19 17 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 19 15 $0.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 13 12 $0.00
72100 12 12 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 88 71 $0.00
J1171 Injection, hydromorphone, 0.1 mg 65 38 $0.00
73030 26 24 $0.00
74018 55 50 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 32 26 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 37 26 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 46 40 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 51 48 $0.00
73630 236 209 $0.00
76705 Ultrasound, abdominal, real time with image documentation; limited 27 27 $0.00
C9113 Injection, pantoprazole sodium, per vial 34 24 $0.00